$69advertised
Semaglutide
Under a sale banner: "Save $250 Every Month"
Billing term not stated, so we do not compare it
3 figures published, none with a billing term
✓ Figure read 16 Nov 2026
Head-to-head comparison
Gala Health's lowest advertised GLP-1 figure is $69 (Under a sale banner: "Save $250 Every Month"), checked 16 Nov 2026. It does not state how long a plan runs. At its lowest dated price, Ivim Health costs $139.99 a month (12-month plan, $780 for the medication at this rate): $65 for medication plus a $74.99 membership fee, checked 16 Nov 2026. We don't call either one cheaper. The figures are not like for like: Gala Health states no billing term for its figures; we last checked Gala Health's membership fee more than a month ago; Ivim Health does not say whether it bills its program monthly or up front.
They differ on 1 of the 7 things we track and match on 1. On the other 5, we lack the fact for one of them or both.
We earn a commission on paid links. How we make money
We track prices, terms and availability. We are not clinicians, this page is not medically reviewed, and nothing here is medical advice. Talk to a licensed clinician about whether a GLP-1 medication is right for you.
$69advertised
Semaglutide
Under a sale banner: "Save $250 Every Month"
Billing term not stated, so we do not compare it
3 figures published, none with a billing term
✓ Figure read 16 Nov 2026
First year, all in
$139.99/mo total, 12-month plan
Price checked 16 Nov 2026
FDA letter, Feb 2026 8.7/10 VerifiedDose scoreMore columns to the right. Drag or swipe the table.
| Term |
Gala Health
|
|
|---|---|---|
| From $/mo | not published | $65 compounded semaglutide, 12-month plan Verified 16 Nov 2026 |
| Membership fee | $0 Verified 21 Oct 2026 | $74.99 Verified 16 Nov 2026 |
| Insurance | Not recorded | Files insurance claims |
| Cancellation | Not documented | Online, self-service |
Rows where both providers state the same thing are left out on purpose. Every price here carries the date we read it from the provider's own pages; a figure with no date reads "not published" rather than being estimated. Not on file for either provider: states covered, time to prescription.
A lower price does not establish clinical suitability or quality of care. We compare what these companies publish about cost and terms, and nothing here measures the medicine or the service behind it.
Verdict: Gala Health publishes its prices without a billing term, so we cannot set them against Ivim Health's 12-month programs. We can compare the fees and the paperwork. Gala charges no membership fee: we recorded its fee as zero. Ivim adds a monthly membership fee that runs as long as your program. Each provider's review lists every figure we hold, with its date.
Gala's pages give a monthly price for each medication and a lower figure to start, but no plan length. Its FAQ says the final price depends on the plan and medication you pick at checkout. Ivim labels its prices "12 months of" and prices none of the shorter programs its FAQ lists. Until Gala publishes its terms, ask it in writing what you would be billed and for how long.
Gala charges no membership fee on top of the medication. Ivim adds one every month, shown in the table with its date, and its membership must run the length of your program. Ivim lets you cancel online in your account. We found no cancellation route in Gala's published terms, so ask Gala in writing how to leave before you commit.
We have no record either way. Ivim's terms say it files insurance claims.
We could not establish that. No billing term is established for either medication's price.
Ratings weigh verified price, total first-year cost, state availability, speed to prescription, cancellation terms and regulatory record. Full scoring rubric.
We are not clinicians and this page carries no clinical review. Drug and regulatory facts are cited directly from FDA, CMS and court records, never a provider's marketing claims.
When you sign up with a provider through our links, we may earn a referral fee. Fees never influence a rating, a price, or a position in a table. Full advertiser disclosure.